shot-button
Subscription Subscription
Home > News > World News > Article > Canada wont use 3 lakh JJ vaccine doses over quality issue

Canada won’t use 3 lakh J&J vaccine doses over ‘quality’ issue

Updated on: 13 June,2021 08:30 AM IST  |  Ottawa
Agencies |

To ensure the safety of any future vaccine supply from this facility, Health Canada is planning an on-site inspection, expected to take place later this year

Canada won’t use 3 lakh J&J vaccine doses over ‘quality’ issue

A man receives a dose of Johnson & Johnson vaccine at Miami International Airport, in Miami. Pic/AFP

The state-run Health Canada said that it will not use the 3,00,000 Johnson & Johnson Covid-19 vaccine doses, which arrived in the country in April due to a possible quality issue.


“To protect the health and safety of Canadians in response to concerns regarding a drug substance produced at the Emergent BioSolutions facility in Baltimore Maryland, Health Canada will not be releasing the shipment,” the government department said in a statement on Friday.



The moves comes after it emerged that an active ingredient was made at an American facility that has been flagged by the US’ Food and Drugs Administration (FDA).


“The drug substance was manufactured at the time a separate batch of vaccines was contaminated by the components of a different vaccine. Health Canada was unable to determine that this shipment of Janssen vaccines [the arm of J&J that specialises in vaccines and biopharmaceutical technologies] meets the Department’s rigorous quality standards,” the statement added.

“Until this inspection has been completed, Canada will not be accepting any product or ingredients made at this site,” it said. The statement was issued after the US FDA said on Friday that Johnson & Johnson must discard millions of doses of its Covid-19 vaccine that were manufactured at the Baltimore facility. 

The FDA halted production at the Baltimore site after discovering that ingredients from AstraZeneca’s Covid-19 vaccine also being produced at the plant at the time contaminated a batch of Johnson & Johnson

Brazil approves Pfizer for kids aged 12 and up

Brazil’s health regulator approved the Pfizer vaccine on Friday for use in children aged 12 and up, though they will likely have to wait months in line for older age groups to be vaccinated first. Supply issues mean the move is mainly symbolic for now. Brazil’s vaccination drive has been hit by shortages and delays.

Also Read: A mob blocked me, threatened to set me on fire: Doctor

17,61,07,846
TOTAL Number OF CORONAVIRUS

CASES IN THE WORLD

38,02,195
Number OF DEATHS WORLDWIDE 

15,97,01,936
Number OF RECOVERED PATIENTS

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK